These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 26211978)

  • 21. Progesterone down-regulates spinal cord inflammatory mediators and increases myelination in experimental autoimmune encephalomyelitis.
    Garay LI; González Deniselle MC; Brocca ME; Lima A; Roig P; De Nicola AF
    Neuroscience; 2012 Dec; 226():40-50. PubMed ID: 23000619
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diosgenin ameliorates cellular and molecular changes in multiple sclerosis in C57BL/6 mice.
    Zeinali H; Baluchnejadmojarad T; Roghani M
    Mult Scler Relat Disord; 2021 Oct; 55():103211. PubMed ID: 34425463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of relapsing-remitting and chronic forms of experimental autoimmune encephalomyelitis in C57BL/6 mice.
    Berard JL; Wolak K; Fournier S; David S
    Glia; 2010 Mar; 58(4):434-45. PubMed ID: 19780195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. You-Gui pills promote nerve regeneration by regulating netrin1, DCC and Rho family GTPases RhoA, Racl, Cdc42 in C57BL/6 mice with experimental autoimmune encephalomyelitis.
    Ji X; Liu H; An C; Wang Y; Zhao H; Zhang Q; Li M; Qi F; Chen Z; Wang X; Wang L
    J Ethnopharmacol; 2016 Jul; 187():123-33. PubMed ID: 27106785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Demyelination and early remyelination in experimental allergic encephalomyelitis passively transferred with myelin basic protein-sensitized lymphocytes in the Lewis rat.
    Pender MP; Nguyen KB; Willenborg DO
    J Neuroimmunol; 1989 Dec; 25(2-3):125-42. PubMed ID: 2479658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HMG-CoA reductase inhibitor augments survival and differentiation of oligodendrocyte progenitors in animal model of multiple sclerosis.
    Paintlia AS; Paintlia MK; Khan M; Vollmer T; Singh AK; Singh I
    FASEB J; 2005 Sep; 19(11):1407-21. PubMed ID: 16126908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Focal experimental autoimmune encephalomyelitis in the Lewis rat induced by immunization with myelin oligodendrocyte glycoprotein and intraspinal injection of vascular endothelial growth factor.
    Sasaki M; Lankford KL; Brown RJ; Ruddle NH; Kocsis JD
    Glia; 2010 Oct; 58(13):1523-31. PubMed ID: 20645414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved clinical behavior of established relapsing-remitting experimental autoimmune encephalomyelitis following treatment with endogenous opioids: implications for the treatment of multiple sclerosis.
    Hammer LA; Zagon IS; McLaughlin PJ
    Brain Res Bull; 2015 Mar; 112():42-51. PubMed ID: 25647234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Axon loss is responsible for chronic neurological deficit following inflammatory demyelination in the rat.
    Papadopoulos D; Pham-Dinh D; Reynolds R
    Exp Neurol; 2006 Feb; 197(2):373-85. PubMed ID: 16337942
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Developmental endothelial locus-1 is a homeostatic factor in the central nervous system limiting neuroinflammation and demyelination.
    Choi EY; Lim JH; Neuwirth A; Economopoulou M; Chatzigeorgiou A; Chung KJ; Bittner S; Lee SH; Langer H; Samus M; Kim H; Cho GS; Ziemssen T; Bdeir K; Chavakis E; Koh JY; Boon L; Hosur K; Bornstein SR; Meuth SG; Hajishengallis G; Chavakis T
    Mol Psychiatry; 2015 Jul; 20(7):880-888. PubMed ID: 25385367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin-like growth factor I treatment reduces demyelination and up-regulates gene expression of myelin-related proteins in experimental autoimmune encephalomyelitis.
    Yao DL; Liu X; Hudson LD; Webster HD
    Proc Natl Acad Sci U S A; 1995 Jun; 92(13):6190-4. PubMed ID: 7541143
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-inflammatory, antioxidant and anti-mitophagy effects of trans sodium crocetinate on experimental autoimmune encephalomyelitis in BALB/C57 mice.
    Banaeeyeh S; Afkhami-Goli A; Moosavi Z; Razavi BM; Hosseinzadeh H
    Metab Brain Dis; 2024 Jun; 39(5):783-801. PubMed ID: 38739183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of CB2 receptor is required for the therapeutic effect of ABHD6 inhibition in experimental autoimmune encephalomyelitis.
    Wen J; Ribeiro R; Tanaka M; Zhang Y
    Neuropharmacology; 2015 Dec; 99():196-209. PubMed ID: 26189763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Idazoxan attenuates spinal cord injury by enhanced astrocytic activation and reduced microglial activation in rat experimental autoimmune encephalomyelitis.
    Wang XS; Chen YY; Shang XF; Zhu ZG; Chen GQ; Han Z; Shao B; Yang HM; Xu HQ; Chen JF; Zheng RY
    Brain Res; 2009 Feb; 1253():198-209. PubMed ID: 19083996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside attenuates experimental autoimmune encephalomyelitis via modulation of endothelial-monocyte interaction.
    Prasad R; Giri S; Nath N; Singh I; Singh AK
    J Neurosci Res; 2006 Aug; 84(3):614-25. PubMed ID: 16770773
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FK506 and a nonimmunosuppressant derivative reduce axonal and myelin damage in experimental autoimmune encephalomyelitis: neuroimmunophilin ligand-mediated neuroprotection in a model of multiple sclerosis.
    Gold BG; Voda J; Yu X; McKeon G; Bourdette DN
    J Neurosci Res; 2004 Aug; 77(3):367-77. PubMed ID: 15248293
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunomodulation neuroprotection and remyelination - the fundamental therapeutic effects of glatiramer acetate: a critical review.
    Aharoni R
    J Autoimmun; 2014 Nov; 54():81-92. PubMed ID: 24934599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic effects of cisplatin on rat experimental autoimmune encephalomyelitis.
    Li XB; Schluesener HJ
    Arch Immunol Ther Exp (Warsz); 2006; 54(1):51-3. PubMed ID: 16642257
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin-like growth factor I treatment reduces clinical deficits and lesion severity in acute demyelinating experimental autoimmune encephalomyelitis.
    Liu X; Yao DL; Webster H
    Mult Scler; 1995 Apr; 1(1):2-9. PubMed ID: 9345463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dynamic expression of autophagy-related factors in autoimmune encephalomyelitis and exploration of curcumin therapy.
    Boyao Y; Mengjiao S; Caicai B; Xiaoling L; Zhenxing L; Manxia W
    J Neuroimmunol; 2019 Dec; 337():577067. PubMed ID: 31629984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.